Caplin Point's subsidiary, Caplin One Labs, secured crucial GMP compliance from INVIMA, Colombia.

Caplin Point Laboratories LimitedCAPLIPOINT · Filed with the exchange

This enables its unit to manufacture sterile & non-sterile oncology drugs like injections, tablets, and capsules.

Opens significant market access and growth opportunities in Colombia for these specialized products.

No comments yet. Be the first.

More from Caplin Point Laboratories Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.